Attain Performa(TM) Quadripolar Lead Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1202 participants.
Also called NCT01751022
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 1,202 participants
- Registry
-
NCT01751022
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Australia, Austria, Belgium, Canada, Chile, Denmark, Finland, France, Germany, Greece, Hungary, India, Israel, Italy, Malaysia, Netherlands, Norway, Romania, Saudi Arabia, Serbia, Slovakia, Slovenia, South Africa, Spain, Switzerland, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT01751022. Allocation not applicable; no masking; primary purpose treatment. Start 2012-12 (registry gives no type); primary completion 2015-02 (actual). Results posted on 2016-12-05.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Attain Performa(TM) Quadripolar Lead Study
- Condition
- Heart Failure
- Intervention (Device)
- Device: Attain Performa Pacing Lead (along with a standard CRT-D system)
- Lead sponsor
- Medtronic Cardiac Rhythm and Heart Failure
Record details
- Record id
cardio:ct-nct01751022- Content hash
9839839d5d59903d42c12627a0a996ab0dab179c758147f92b22280253ea4ada